Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 5/20 | 0.41 |
| ▸ | HPGD | P15428 | 3/20 | 0.41 |
| ▸ | HTT | P42858 | 3/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 4/20 | 0.40 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | ACSL1 | P33121 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4866031 | 0.87 | CYP1A2 (0.47) | ALDH1A1KDM4EMAPTHPGDHTT | |
| SCHEMBL4856191 | 0.87 | CYP1A2 (0.47) | ALDH1A1KDM4EMAPTHPGDHTT | |
| SCHEMBL4863473 | 0.82 | CYP3A4 (0.48) | — | |
| SCHEMBL4865782 | 0.82 | CYP3A4 (0.48) | — | |
| SCHEMBL4866610 | 0.81 | ALDH1A1 (0.46) | ALDH1A1KDM4EMAPTHPGDHTT | |
| SCHEMBL4865748 | 0.76 | CYP3A4 (0.47) | POLB | |
| SCHEMBL4861528 | 0.75 | CYP3A4 (0.45) | — | |
| SCHEMBL5965265 | 0.74 | PKM (0.49) | ALDH1A1KDM4EGAASMN1; SMN2ACSL1 | |
| SCHEMBL5901370 | 0.74 | PKM (0.49) | ALDH1A1KDM4EGAASMN1; SMN2ACSL1 | |
| SCHEMBL4040185 | 0.74 | PKM (0.49) | ALDH1A1KDM4EGAASMN1; SMN2ACSL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1806346-A1 | Substituted piperazine compounds and their use as fatty acid oxidation inhibitors | CV THERAPEUTICS, INC. (US) | 2007-07-11 | — | — | EP | disclosed |